Latest News

Journal Articles

Autoimmune

Multiple sclerosis research suggests a neuroprotective benefit following resistance training

Parkinson’s is partly an autoimmune disease, new study states

Autoantibodies in neurological disorders – a review from Judith Greer

Cerebrovascular disease

Cell therapies administered in the chronic phase after stroke: a meta-analysis examining safety and efficacy

Blood protein biomarkers as diagnostic tool for ischemic stroke: a systematic review

RNA as a stroke biomarker

CNS/PNS/SNS

Neurogenesis takes place in the amygdala of mice

Granulin research opens avenues for frontotemporal dementia treatment

Commercializing regenerative medicine in the early days of a revolution: an interview with Mahendra Rao

Cognitive/neurodegenerative disorders

PET scans reveal link between low serotonin levels and dementia

TBI, animal models and neuroimaging: David Brody at Frontiers in TBI

Granulin research opens avenues for frontotemporal dementia treatment

Demyelinating disease

Human herpes virus 6 may hamper the brain's ability to repair damaged cells

World MS Day on Neuro Central – note from the Editor

NCTalks at AAN 2017: Michael Pender on a new multiple sclerosis treatment targeting Epstein-Barr virus

Development and pediatrics

Zika virus update: a note from the Editor

Zika virus: where are we now?

Neurogenesis takes place in the amygdala of mice

Epilepsy and seizure

Polymorphisms in ABCB1 and EPHX1 genes influence drug effectiveness in refractory epilepsy: a retrospective study

Technological advances in pediatric epilepsy surgery: implications for tuberous sclerosis complex

Epilepsy drug receives approval as monotherapy from European Medicines Agency

Genetics

NCTalks at AAIC 2017: Julie Williams on Alzheimer’s genetics

DNA methylation and transcription onset in the brain

Small-molecule BDNF mimetic may improve symptoms of Rett syndrome

Headache

EAN 2017: Monoclonal antibody could be an effective treatment for chronic migraine

EAN 2017: Cannabinoids suitable for migraine prophylaxis

Noninvasive brain stimulation: an interview with Eric Wasserman

Immune disorders and inflammation

EAN 2017: Guillain-Barré syndrome risk associated with month of birth

Parkinson’s is partly an autoimmune disease, new study states

NCTalks at AAN 2017: Michael Pender on a new multiple sclerosis treatment targeting Epstein-Barr virus

Infection

Zika virus update: a note from the Editor

What can climate-driven models teach us about the Zika outbreak?

Zika – an update on the vaccine pipeline

Injury/trauma

'Should we retire the term concussion?': live debate from Frontiers in TBI

TBI, animal models and neuroimaging: David Brody at Frontiers in TBI

CTE pathology and controversy: Lee Goldstein at Frontiers in TBI

Movement disorders

CIRM: Phase III clinical trial targeting Lou Gehrig's disease gets US$15.9 million investment

NCTalks on neuromodulation in children: an interview with Jean-Pierre Lin, President of the British Paediatric Neurology Association

#NCintroduces… Going through the motions: how modern techniques have changed the face of Parkinson’s research

Neuro-ophthalmology

Management of glaucoma as a neurodegenerative disease

Genetic analysis identifies loci associated with macular telangiectasia type 2

The best of 2016 on Neurology Central – a note from the Editor

Neurometabolic

Could the gut microbiome hold the key to neurodegenerative disorders?

The best of 2016 on Neurology Central – a note from the Editor

Energy drinks and alcohol may affect adolescent brains in similar way to cocaine

Neuromuscular

Novel discovery in motor neuron disease may pave the way for future treatments

EAN 2017: Guillain-Barré syndrome risk associated with month of birth

Repurposing of malaria drug to halt ALS disease progression

Neuropsychiatry

Honing in on hormone-sensitive neural targets for therapeutic intervention: mission impossible?

NCTalks at AAIC 2017: Megan Zuelsdorff on lifetime stress, racial disparities and cognitive health

Neurotransmitter receptor genotypes associated with mental and behavioral disorders

Oncology/tumor

Novel drug target identified for glioblastoma treatment

Role of cellular prion protein in neurofibromatosis 2 tumor development uncovered

Alzheimer’s disease patients may have a lower risk of developing lung cancer

Pain

EAN 2017: Monoclonal antibody could be an effective treatment for chronic migraine

EAN 2017: Cannabinoids suitable for migraine prophylaxis

Recent advances in spinal cord stimulation for pain treatment

Sleep

Poor sleep quality associated with presence of Alzheimer’s disease biomarkers

Light, sleep and circadian rhythms in older adults with Alzheimer's disease and related dementias

#NCintroduces… Mammalian chronobiology and circadian rhythms